NCT07168382 AI-Based Personalized Health and Self-Care
| NCT ID | NCT07168382 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emre Sezgin |
| Condition | Social Needs Status |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-04-24 |
| Primary Completion | 2028-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-04-24 with a primary completion date of 2028-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if the DAPHNE chatbot can improve caregiver engagement, usability, and integration of social care support tools into clinical workflows in caregivers of pediatric patients receiving care at the Nationwide Children's Hospital Primary Care Center (NCH PCC). This is a pilot randomized clinical trial. The main questions it aims to answer are: * Is the DAPHNE chatbot usable, acceptable, and minimally burdensome for caregivers over a 6-month period? * Can the DAPHNE chatbot be effectively integrated into primary care provider workflows? Researchers will compare the DAPHNE chatbot intervention arm to the standard of care control arm to see if the intervention improves caregiver-reported outcomes and provider workflow integration. Participants that are patients will be randomly assigned to either the DAPHNE chatbot group or the standard of care group. Complete surveys assessing usability, acceptability, and burden and participate in brief qualitative interviews to share feedback on their experience. Participants that are Primary Care providers will discuss integration of DAPHNE into clinical workflows and complete workflow integration assessments.
Eligibility Criteria
Inclusion Criteria (Caregivers): * Must be a caregiver of a child seen within the NCH primary care network who self-identifies with at least one unmet social need * Must be 18 years of age or older * Must be English-speaking * Must have a device that connects to the internet Inclusion Criteria (Primary Care Providers and Support Team Members): * Must be 18 years or older * Must be employed at Nationwide Children's Hospital Exclusion Criteria: \- Due to the intervention only being translated into English, non-English Speakers will be excluded from this study.
Contact & Investigator
Emre Sezgin, PhD
PRINCIPAL INVESTIGATOR
Nationwide Children's Hospital
Frequently Asked Questions
Who can join the NCT07168382 clinical trial?
This trial is open to participants of all sexes, studying Social Needs Status. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07168382 currently recruiting?
Yes, NCT07168382 is actively recruiting participants. Contact the research team at Emre.Sezgin@nationwidechildrens.org for enrollment information.
Where is the NCT07168382 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT07168382 clinical trial?
NCT07168382 is sponsored by Emre Sezgin. The principal investigator is Emre Sezgin, PhD at Nationwide Children's Hospital. The trial plans to enroll 70 participants.